Posts tagged “Biotech & Life Science”
Dr. Robert Califf, one of the nation's leading medical researchers, joined the Food and Drug Administration on Monday, taking on the agency's No. 2 leadership job at a critical juncture for prescription drugs, medical devices and tobacco products.
A newly released report from research firm Battelle documents the continuing growth of the biotech industry across North Carolina. Jobs are up, economic impact is surging, and average salaries are at $81,000. In fact, biotech employment grew more than 30 percent between 2000 and 2012 compared to an overall job growth rate of 1 percent.
Inside the Battelle "Impact of Life Sciences in North Carolina" report: A break down on Biogen's "interactions," from jobs to partnerships and money spent with vendors.
Drug giants GlaxoSmithKline and Novartis say they have formally closed on a deal valued at more than $21 billion to changes each company in dramatic fashion. Plus, they are moving ahead with a joint venture focusing on consumer healthcare.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
In today's Bulldog wrapup of business and technology news: Google places ads in Android apps store; Uber strikes a deal with hotel chain; Cempra looks for big 2015; Nickelodeon's new app; WhatsApp suspended in Brazil.
Reddit, Google crack down on nude photos; GSK-Novartis deal nears close; Apple loses $539.M dispute; INC's first results; honor for Quintiles
In today's Bulldog wrapup of technology and life science news: Reddit and Google are cracking down on nude photos; GSK says Novartis deal nears close; Apple loses a big patent verdict; INC reports results; an honor for Quintiles.
GlaxoSmithKline's diet pill "alli" is now back in most U.S. stores. The drugmaker voluntary recalled the product last March after finding some packages in stores didn't contain real alli, indicating tampering after shipment.
Bronto's upbeat update; IBM targets hybrid cloud; Quintiles' new exec; YouTube for Kids half-baked?; Comcast earnings
In today's Bulldog wrapup of technology and life science news: Bronto's CEO offers a 2014 review via YouTube; IBM targets hybrid cloud; Quintiles adds a new exec; VentureBeat writer criticizes new YouTube for Kids; and Comcast income rises.
In a presentation to investors, Valeant executives on Monday spelled out in great deal why the Canadian firm decided to buy Raleigh-based Salix in a deal worth $14 billion. We've got a slide show about the Valeant presentation.
GSK-Novartis deal OK'd; Apple's $1.92B data centers; Argos buying HQ; Dish founder bis back; CommScope earnings
In today's Bulldog wrapup of technology and life science news: The FTC approves the Novartis-GSK cancer drug deal; Apple plans new data centers in Europe; Argos is buying its new headquarters; Dish founder back as CEO; and CommScope reports a profit.
Shares in Valeant Pharmaceuticals jumped 14 percent but Salix Pharmaceuticals fell slightly on Monday once stock markets opened and reacted to Sunday's announcement that Valeant is buying Salix in a deal valued at $14 billion. Three law firms are looking into the deal.
Raleigh-based BioDelivery Sciences will receive a $10 million milestone payment from partner Endo Pharmaceuticals now that the FDA has accepted a new drug application for the severe pain reliever system known as Belbuca.
Raleigh-based Salix Pharmaceuticals could have to pay as much as $400 million if its $14 billion deal to be acquired by Valeant falls through. Salix says it will not seek another offer but if another comes along and Salix accepts it, Valeant would be paid a termination fee of $356M plus related costs up to $50M.
Raleigh-based Salix Pharmaceuticals has agreed to be acquired by Canadian drugmaker Valeant Pharmaceuticals in a deal valued at some $14 billion. The boards of both companies have already agreed to the terms, which were announced Sunday.
Sunday's announced acquisition of Salix by Valeant will not quite the turmoil that has engulfed one of the Triangle's best pharmaceutical success stories. In fact, in the short term, life is likely to get worse in a merger that is likely to lead to job cuts as part of $500 million in cost savings. Plus, the Triangle is losing another corporate headquarters.
Why give your doctors permission to incorporate data from fitness trackers and health apps into electronic patient records? Well, they might spot signs of an ailment sooner and suggest behavioral changes or medication before you land in the emergency room. They also might be able to monitor how you're healing from surgery or whether you're following a treatment regimen.